# Zimmer Biomet Holdings Moat

Status: published. Policy: company-analysis-1.

Zimmer Biomet has an established surgical support and consignment infrastructure, customer relationships and proprietary products. The supplied passages do not establish that these produce durable switching costs or technological superiority. Pricing power is weak: prices reduced first-half 2026 sales by 0.7%, including purchase incentives. Continuing demand and innovation provide offsets, but procurement pressure, margin compression and distribution disruption show erosion. Insufficient evidence of a durable moat does not establish interchangeable offerings or uniformly low barriers.

## switching_costs

Product-specific technical support, professional relationships and consigned inventory constitute an existing service infrastructure that could create switching friction; customer dependence and the cost of changing suppliers are not demonstrated.

Durability: The infrastructure is established, but its ability to protect demand or pricing over time remains unproven.

Risks: Purchasing-group members have no purchase obligation, most sales lack firm orders, and customer relationships partly depend on personnel and distributors. China distribution changes have generated actual claims.

Invalidation: The switching-cost hypothesis would be invalidated by documented customer migration despite continued technical support and inventory availability, or evidence that replacement suppliers require little retraining or operational adjustment.

Competitors: Not established
## intangible_assets

Proprietary technology and intellectual-property protections are current assets. Reported ROSA Shoulder clearance and first cases demonstrate development progress, but neither those achievements nor acquired robotics establish sustained competitive superiority.

Durability: No product-specific exclusivity duration, durable clinical advantage or sustained premium pricing is established. Monogram's anticipated contribution remains potential.

Risks: Technology can be circumvented or independently replicated, and commercial acceptance requires continued innovation. Realized price declines limit evidence of monetizable differentiation.

Invalidation: The differentiation hypothesis would be invalidated by equivalent competing technology eliminating product preference, loss of commercially important exclusivity, or persistent adoption weakness after cleared products become available.

Competitors: Not established
- [https://www.sec.gov/Archives/edgar/data/1136869/000119312526059853/zbh-20251231.htm](https://www.sec.gov/Archives/edgar/data/1136869/000119312526059853/zbh-20251231.htm) · 2026-02-20
- [https://www.sec.gov/Archives/edgar/data/1136869/000119312526335044/zbh-20260630.htm](https://www.sec.gov/Archives/edgar/data/1136869/000119312526335044/zbh-20260630.htm) · 2026-08-05
- [https://www.sec.gov/Archives/edgar/data/1136869/000119312526135661/zbh-20260331.htm](https://www.sec.gov/Archives/edgar/data/1136869/000119312526135661/zbh-20260331.htm) · 2026-04-01
- [https://www.sec.gov/Archives/edgar/data/1136869/000095017025026604/zbh-20241231.htm](https://www.sec.gov/Archives/edgar/data/1136869/000095017025026604/zbh-20241231.htm) · 2025-02-25
- [https://www.sec.gov/Archives/edgar/data/1136869/000095017024019353/zbh-20231231.htm](https://www.sec.gov/Archives/edgar/data/1136869/000095017024019353/zbh-20231231.htm) · 2024-02-23
- [https://www.sec.gov/Archives/edgar/data/1136869/000119312526201710/zbh-20260331.htm](https://www.sec.gov/Archives/edgar/data/1136869/000119312526201710/zbh-20260331.htm) · 2026-05-01
- [https://www.sec.gov/Archives/edgar/data/1136869/000119312526385256/d304716dex991.htm](https://www.sec.gov/Archives/edgar/data/1136869/000119312526385256/d304716dex991.htm) · 2026-09-08
- [https://www.sec.gov/Archives/edgar/data/1136869/000119312526333761/zbh-ex99_1.htm](https://www.sec.gov/Archives/edgar/data/1136869/000119312526333761/zbh-ex99_1.htm) · 2026-08-05
- [https://www.sec.gov/Archives/edgar/data/1136869/000119312526218098/zbh-ex99_1.htm](https://www.sec.gov/Archives/edgar/data/1136869/000119312526218098/zbh-ex99_1.htm) · 2026-05-12

[JSON](https://beanvest.com/stock/zbh/moat.json)